GLPwatch
Exendin-4 - A potential therapeutic for type 2 diabetes-linked cervical cancer?
EBioMedicine · 2021
Last updated 2026-05-28| Journal | EBioMedicine, 2021 |
|---|---|
| Citations | 0 |
| Relative citation ratio | 0.00 |
| NIH percentile | 0 |
| Molecules | — |
| Conditions studied | Type 2 Diabetes |
Full record and abstract on PubMed 33714887 ↗